Techulon

Techulon is solving for the dangerous and growing problem of "superbugs"; bacteria that have become resistant to many or all known antibiotics

  • Stage Product In Development
  • Industry Biotechnology
  • Location Blacksburg, VA, US
  • Currency USD
  • Founded January 2007
  • Employees 4
  • Incorporation Type C-corp
  • Website techulon.com

Company Summary

Techulon has developed a platform technology for gene targeting. The use of this technology yields a new class of novel therapeutics that are as efficacious as current therapies while mitigating negative effects of current antibiotics. Resistance development is also mitigated. Application of this technology addresses Gram positive and Gram negative pathogens using systemic treatment as well as wound dressing/topical gel delivery mechanism.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free